Page last updated: 2024-08-23

etoposide and Cardiovascular Diseases

etoposide has been researched along with Cardiovascular Diseases in 15 studies

Research

Studies (15)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (13.33)18.2507
2000's5 (33.33)29.6817
2010's7 (46.67)24.3611
2020's1 (6.67)2.80

Authors

AuthorsStudies
Agerbæk, M; Andersen, KK; Bandak, M; Daugaard, G; Dehlendorff, C; Gundgaard Kier, MG; Gupta, R; Hansen, MK; Holm, NV; Kreiberg, MB; Lauritsen, J; Skøtt, JW; Wagner, T1
Ardeshir-Rouhani-Fard, S; Beard, CJ; Cook, R; Einhorn, LH; Feldman, DR; Fossa, SD; Fung, C; Hamilton, RJ; Lipshultz, SE; Monahan, P; Oeffinger, KC; Sesso, HD; Travis, LB; Vaughn, DJ; Williams, AM; Zaid, MA1
Dumas, I; Ferrer, L; Guillem, P; Lattuca-Truc, M; Levra, MG; Moro-Sibilot, D; Pinsolle, J; Ruckly, S; Timsit, JF; Toffart, AC; Villa, J1
Agerbaek, M; Christensen, IJ; Daugaard, G; Gupta, R; Kier, MGG; Lauritsen, J; Mortensen, MS1
Altena, R; Boer, H; Gietema, JA; Kamphuisen, PW; Lefrandt, JD; Lubberts, S; Meijer, C; Mulder, AB; Nuver, J; Oosting, SF; Smit, AJ; van Roon, AM; Zwart, N1
Bremnes, RM; Brydøy, M; Fosså, SD; Gundersen, POM; Haugnes, HS; Hjelle, LV; Oldenburg, J; Sprauten, M; Tandstad, T; Wilsgaard, T1
Bonfante, V; Busia, A; Laffranchi, A; Villani, F; Villani, M; Viviani, S1
Bonfante, V; Busia, A; Laffranchi, A; Villani, F; Viviani, S1
Carmichael, C; Ferrell, B; Frankel, P; Hsu, J; Margolin, K; Pal, SK; Saikia, J; Stein, CA; Sun, V; Twardowski, P; Yamzon, J1
Birtle, AJ; Huddart, RA1
Seiter, K1
Gietema, JA; Hoekstra, HJ; Meinardi, MT; Nuver, J; Sleijfer, DT; Smit, AJ; van den Berg, MP; van der Graaf, WT; van der Meer, J; van Gessel, AI; van Roon, AM1
Brugger, W; Engelhardt, R; Fetscher, S; Frommhold, H; Hasse, J; Kanz, L; Lange, W; Mertelsmann, R; Wenger, M1
Advani, R; Davis, E; Dugan, K; Greenberg, PL; Litchman, M; Lum, B; Paietta, E; Ramek, J; Rowe, JM; Saba, HI; Sikic, BI; Tallman, MS; Villena, J; Wiernik, PH1
Sweeney, C1

Reviews

3 review(s) available for etoposide and Cardiovascular Diseases

ArticleYear
Recent advances in the treatment of testicular cancer.
    Expert review of anticancer therapy, 2005, Volume: 5, Issue:1

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cardiovascular Diseases; Chemotherapy, Adjuvant; Cisplatin; Etoposide; Humans; Male; Neoplasm Staging; Neoplasms, Second Primary; Prognosis; Risk Factors; Seminoma; Testicular Neoplasms

2005
Toxicity of the topoisomerase II inhibitors.
    Expert opinion on drug safety, 2005, Volume: 4, Issue:2

    Topics: Antineoplastic Agents; Cardiovascular Diseases; Daunorubicin; Doxorubicin; Enzyme Inhibitors; Epirubicin; Etoposide; Humans; Idarubicin; Leukemia; Middle Aged; Mitoxantrone; Mucositis; Podophyllotoxin; Teniposide; Topoisomerase II Inhibitors; Vascular Diseases

2005
History of testicular cancer chemotherapy: maximizing efficacy, minimizing toxicity.
    Seminars in urologic oncology, 2001, Volume: 19, Issue:3

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow; Cardiovascular Diseases; Cisplatin; Etoposide; Germinoma; Hearing Disorders; Humans; Infertility, Male; Male; Nausea; Nervous System Diseases; Testicular Neoplasms; Vinblastine; Vomiting

2001

Trials

3 trial(s) available for etoposide and Cardiovascular Diseases

ArticleYear
Acute chemotherapy-induced cardiovascular changes in patients with testicular cancer.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2005, Dec-20, Volume: 23, Issue:36

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Biomarkers; Bleomycin; Cardiovascular Diseases; Carotid Arteries; Cisplatin; Etoposide; Humans; Male; Middle Aged; Predictive Value of Tests; Prognosis; Prospective Studies; Testicular Neoplasms; Tunica Intima; von Willebrand Factor

2005
Dose-intense therapy with etoposide, ifosfamide, cisplatin, and epirubicin (VIP-E) in 100 consecutive patients with limited- and extensive-disease small-cell lung cancer.
    Annals of oncology : official journal of the European Society for Medical Oncology, 1997, Volume: 8, Issue:1

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Diseases; Carboplatin; Carcinoma, Small Cell; Cardiovascular Diseases; Cisplatin; Combined Modality Therapy; Disease-Free Survival; Epirubicin; Etoposide; Feasibility Studies; Female; Granulocyte-Macrophage Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Lung Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Pneumonectomy; Remission Induction; Survival Analysis; Transplantation Conditioning; Treatment Outcome

1997
Treatment of refractory and relapsed acute myelogenous leukemia with combination chemotherapy plus the multidrug resistance modulator PSC 833 (Valspodar).
    Blood, 1999, Feb-01, Volume: 93, Issue:3

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; ATP Binding Cassette Transporter, Subfamily B, Member 1; Bone Marrow; Cardiovascular Diseases; Cohort Studies; Cyclosporins; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Etoposide; Female; Filgrastim; Granulocyte Colony-Stimulating Factor; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Infections; Leukemia, Myeloid; Male; Middle Aged; Mitoxantrone; Neoplasm Proteins; Recombinant Proteins; Remission Induction; Treatment Outcome

1999

Other Studies

9 other study(ies) available for etoposide and Cardiovascular Diseases

ArticleYear
Cardiovascular Risk Factors and Disease After Male Germ Cell Cancer.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2020, 02-20, Volume: 38, Issue:6

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cardiovascular Diseases; Cisplatin; Etoposide; Humans; Male; Middle Aged; Neoplasms, Germ Cell and Embryonal; Radiotherapy; Risk Factors; Testicular Neoplasms

2020
Predicting Cardiovascular Disease Among Testicular Cancer Survivors After Modern Cisplatin-based Chemotherapy: Application of the Framingham Risk Score.
    Clinical genitourinary cancer, 2018, Volume: 16, Issue:4

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cancer Survivors; Cardiovascular Diseases; Cisplatin; Etoposide; Humans; Male; Middle Aged; Risk Factors; Testicular Neoplasms; Young Adult

2018
Trends in response rate and survival in small-cell lung cancer patients between 1997 and 2017.
    Lung cancer (Amsterdam, Netherlands), 2019, Volume: 131

    Topics: Aged; Bridged-Ring Compounds; Cardiovascular Diseases; Etoposide; Female; France; Humans; Liver Diseases; Lung Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Platinum Compounds; Prognosis; Small Cell Lung Carcinoma; Survival Analysis; Taxoids

2019
Renal impairment and late toxicity in germ-cell cancer survivors.
    Annals of oncology : official journal of the European Society for Medical Oncology, 2015, Volume: 26, Issue:1

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cardiovascular Diseases; Cisplatin; Etoposide; Female; Glomerular Filtration Rate; Humans; Male; Middle Aged; Neoplasms, Germ Cell and Embryonal; Renal Insufficiency; Young Adult

2015
Vascular fingerprint and vascular damage markers associated with vascular events in testicular cancer patients during and after chemotherapy.
    European journal of cancer (Oxford, England : 1990), 2016, Volume: 63

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Biomarkers; Bleomycin; Cardiovascular Diseases; Carotid Intima-Media Thickness; Cisplatin; Etoposide; Factor VIII; Glycation End Products, Advanced; Humans; Male; Middle Aged; Prospective Studies; Testicular Neoplasms; von Willebrand Factor; Young Adult

2016
Associations between long-term serum platinum and neurotoxicity and ototoxicity, endocrine gonadal function, and cardiovascular disease in testicular cancer survivors.
    Urologic oncology, 2016, Volume: 34, Issue:11

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cancer Survivors; Carboplatin; Cardiovascular Diseases; Cisplatin; Combined Modality Therapy; Comorbidity; Etoposide; Follow-Up Studies; Hearing Loss; Humans; Hypogonadism; Luteinizing Hormone; Male; Middle Aged; Norway; Orchiectomy; Peripheral Nervous System Diseases; Surveys and Questionnaires; Testicular Neoplasms; Tinnitus; Vinblastine; Young Adult

2016
Cardiopulmonary response to exercise in patients with different degrees of lung toxicity after radio-chemotherapy for Hodgkin's disease.
    Anticancer research, 2009, Volume: 29, Issue:2

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cardiovascular Diseases; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; Doxorubicin; Epirubicin; Etoposide; Exercise; Female; Hodgkin Disease; Humans; Lung Diseases; Male; Mechlorethamine; Middle Aged; Prednisone; Procarbazine; Radiation Injuries; Vinblastine; Vincristine; Young Adult

2009
Cardiopulmonary toxicity of different chemoradiotherapy combined regimens for Hodgkin's disease.
    Anticancer research, 2010, Volume: 30, Issue:10

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cardiovascular Diseases; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; Doxorubicin; Epirubicin; Etoposide; Female; Hodgkin Disease; Humans; Lung Diseases; Male; Mechlorethamine; Middle Aged; Oxygen Consumption; Prednisone; Procarbazine; Radiation Injuries; Radiotherapy; Vinblastine; Vincristine; Young Adult

2010
Paclitaxel-based high-dose chemotherapy with autologous stem cell rescue for relapsed germ cell tumor: clinical outcome and quality of life in long-term survivors.
    Clinical genitourinary cancer, 2013, Volume: 11, Issue:2

    Topics: Adolescent; Adult; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cardiovascular Diseases; Disease-Free Survival; Etoposide; Female; Humans; Ifosfamide; Male; Middle Aged; Neoplasms, Germ Cell and Embryonal; Paclitaxel; Quality of Life; Stem Cell Transplantation; Surveys and Questionnaires; Survivors; Treatment Outcome; Young Adult

2013